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ABSTRACT
Although adrenergic b 2-agonist-induced smooth
muscle relaxation has been attributed to increased
intracellular cyclic AMP (cAMP), a relaxation response
has been observed at low b 2-agonist concentrations
that do not cause increased cAMP. To elucidate the
mechanism of tracheal muscle relaxation induced by
low concentrations of b 2-agonists, we used a guinea-
pig skinned tracheal smooth muscle preparation to
examine the effects on the contractile protein system.
The isotonic contraction of b -escin-treated skinned
tracheal muscle from guinea-pig was measured. When
the intracellular Ca2+ concentration was maintained at
1 m mol/L in the presence of guanosine 5¢ -triphosphate
(GTP; 100 m mol/L), neither isoproterenol (10 nmol/L)
nor salbutamol (60 nmol/L) affected Ca2+ sensitivity,
but a significant decrease in Ca2+ sensitivity was
observed in the presence of okadaic acid (1 m mol/L).
The decrease in Ca2+ sensitivity was a slow response
and was blocked by pretreatment with propranolol 
(1 m mol/L). Forskolin (1 m mol/L) did not affect Ca2+
sensitivity. These results suggest that adrenergic
b 2-agonists may activate protein phosphatase through
an unknown pathway involving the b 2-receptor, which
enhances dephosphorylation of the myosin light chain
and/or thin filament proteins, resulting in relaxation of
the tracheal smooth muscle.
Key words: adrenergic b 2-agonists, b -escin, guinea-
pig, okadaic acid, skinned tracheal muscle.
INTRODUCTION
Adrenergic b 2-agonists are fast-acting and potent broncho-
dilators used widely as a first-choice inhalant for asthma
attacks even if the patient is receiving corticosteroids.
However, some mechanisms of the bronchodilating effect
of b 2-agonists remain unclear.
Interestingly, the magnitude of the increase of intra-
cellular cyclic AMP (cAMP) in smooth muscle during
b 2-agonist administration does not reflect the degree of
the relaxing response,1,2 although many studies have
reported a correlation between the increase in cAMP and
the relaxing action.3–6 The latter studies that reported a
cAMP increase used drug concentrations that exceeded
the maximum response in the relaxation curve.
What triggers the expression of the relaxing action of
adrenergic b 2-agonists? A decrease in intracellular Ca2+
level has been reported during tracheal smooth muscle
relaxation.7,8 Several mechanisms are involved in this
decreased Ca2+ level, and they can be broadly divided
into the inhibition of Ca2+ influx,8–11 increase of Ca2+
uptake to the store site8,12 and the enhancement of Ca2+
efflux.13,14
To investigate the mechanisms of cAMP-independent
tracheal muscular relaxation, we used adrenergic b 2-
agonists at the concentrations that induced maximum
relaxation without a cAMP increase. We examined the
relaxing actions of isoproterenol (ISO) and salbutamol
(Salb) using skinned preparations of guinea-pig tracheal
muscle, which were devoid of plasma membrane func-
tions such as ion channels and membrane excitability.
METHODS
Preparation of tracheal skinned muscle
A female Hartley strain guinea-pig (bodyweight 200–
250 g) was decapitated at the cervical vertebrae and
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exsanguinated under pentobarbital sodium (30 mg/ kg,
i.p.) anesthesia. The trachea was removed and im-
mediately immersed in a normal external solution (NES;
150 mmol/L NaCl, 4 mmol/L KCl, 2 mmol/L calcium
methanesulfonate, 1 mmol/L magnesium methanesul-
fonate, 10 mmol/L glucose, and 5 mmol/L N-2-hydroxy-
ethylpiperazine-N’-2-ethanesulfonic acid (HEPES), pH 7.4).
Skinned muscle was prepared by a modified method
of Watanabe and Nakano.15 The isolated trachea was cut
open along the center of the cartilages in NES at room tem-
perature. The two ends were fixed on a resin support. The
mucosal and serosal layers were removed carefully to
expose the tracheal smooth muscle layer. Minute muscle
bundle samples measuring 200 m m in width and 1 mm in
length were prepared. Two stainless steel hooks (approxi-
mately 100 m m in thickness) were passed through the
cartilage on both ends of a muscle sample. The hook on
one end was stabilized, and the other hook was connected
by a silk thread to an isotonic transducer (AS2103, Sanei).
The change in the length of the muscle bundle sample was
measured as an index of contraction. A minute sample
loaded with 0.2 g of force was equilibrated in NES for 
30 min at 25°C. After confirming the contractibility using
100 m mol/L acetylcholine, the sample was incubated for
60–90 min in a cytoplasm substitution solution (CSS) con-
taining Ca2+ (3 m mol/L) and b -escin (50 m mol/L), and the
resulting muscle bundle was used as the skinned muscle.
The CSS contained 200 mmol/L potassium methane-
sulfonate, 1.5 mmol/L magnesium methanesulfonate,
3.5 mmol/L MgATP, 10 mmol/L creatine phosphate and
20 mmol/L PIPES (pH 7.0). The CSS used to contract
skinned strips was dissolved in 10 mmol/L O,O’-bis(2-
aminoethyl) ethylene-glycol N,N,N’,N’- tetraacetic acid
(EGTA). To obtain the various Ca2+ concentrations used in
the experiment, the Ca2+ concentration in the CSS was
adjusted by changing the ratio of EGTA/Ca-EGTA. The 
dissociation constant of Ca-EGTA was assumed to be 
106.4 M-1. This constant was used to calculate the Ca2+
concentration in the CSS.15,16
Measurement of isotonic contraction of
skinned muscle
A b -escin-treated skinned muscle was washed in
Ca2+-free CSS and treated with A23187 (10 m mol/L)
for 20 min to remove the Ca2+ in the sarcoplasmic retic-
ulum. After the contraction of the muscle had reached
a plateau at a fixed Ca2+ concentration (1 m mol/L), the
muscle was transferred to a well (420 m L) containing
specific concentrations of test substances and the
response was recorded. The contraction induced by a
substance was determined by setting the length of the
muscle sample in Ca2+-free medium at 0, and assigning
the contraction of the sample induced by guanosine
5¢ -triphosphate (GTP) or okadaic acid (OA) in the
presence of 1 m mol/L Ca2+ as 100%. The change in
muscle length induced by a substance was expressed as 
a percentage. All experiments were conducted at 25°C
using CSS supplemented with calmodulin (1 m mol/L).
Determination of intracellular cAMP levels
The intracellular cAMP level in the smooth muscle of the
intact tracheal tissue after ISO, Salb or forskolin (Fors)
treatment was measured by an enzyme immunoassay.
An intact tracheal muscle strip (1 mm · 7 mm) with
cartilage removed was loaded with 0.5 g of force. After
incubating in 5 mL Krebs-HEPES solution (110.5 mmol/L
NaCl, 5 mmol/L KCl, 1.8 mmol/L CaCl2, 1.2 mmol/L
MgCl2, 1 mmol/L NaH2PO4, 11.5 mmol/L glucose
and 24.5 mmol/L HEPES; pH 7.4) supplemented with
3-isobutyl-1-methylxanthine (0.1 mmol/L) for 30 min at
37°C under 100% O2, the test substance was added
and allowed to react for 16 min. The reaction was then
stopped by adding ice-cold trichloroacetic acid (12%;
w/v). The sample was homogenized in a glass homog-
enizer. The homogenate was centrifuged at 2000 g,
4°C for 15 min. The supernatant was extracted by ether,
and the aqueous layer was dried under N2 gas at 60°C.
The cAMP concentration in the resulting sample was
measured using a cAMP enzyme-immunoassay system
(Amersham). The protein concentration in the sample
was measured according to Lowry’s method.17
Statistical analyses
The data are expressed as mean ± SEM. After perform-
ing a test for equal variance, the differences of the mean
values were analyzed using a one-tailed unpaired t-test.
Chemicals
The concentrations of chemicals are expressed in molar
concentration of the active substance. The following
chemicals were used: A23187 (Calbiochem, San Diego,
CA, USA); acetylcholine hydrochloride (Daiichi Seiyaku
Co Ltd, Tokyo, Japan); adenosine 3’,5’-cyclic mono-
phosphate (cAMP; Sigma Chemical Co., St Louis, MO,
USA); adenosine 5’-triphosphoric acid disodium salt
(ATP; Wako Pure Chemical Industries, Osaka, Japan); 
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b -escin (Sigma); calmodulin (Sigma); cAMP enzyme-
immunoassay system (Amersham Co., Tokyo, Japan);
O,O¢ -bis (2-aminoethyl) ethylene-glycol-N,N,N’,N’-tetra-
acetic acid (EGTA; Wako Pure Chemical Industries);
forskolin (Wako Pure Chemical Industries); HEPES (N-2-
hydroxyethylpiperazine-N-2-ethanesulfonic acid; Wako
Pure Chemical Industries); 3-isobutyl-1-methylxanthine
(Aldrich Chemical Co. Inc., Milwaukee, WI, USA); piper-
azine-1, 4-bis(2-ethanesulfonic acid) (PIPES; Wako Pure
Chemicals); ± isoproterenol hydrochloride (Sigma); sal-
butamol sulfate (Wako Pure Chemical Industries, Osaka,
Japan); okadaic acid ammonium (RBI, Natick, MA, USA).
RESULTS
Changes in intracellular cAMP level induced
by adrenergic b 2-agonists or Fors
The concentrations of b 2-agonists and Fors used in the
experiments were the concentrations that produced maxi-
mum relaxation of guinea-pig isolated tracheal muscle
strips in an organ bath determined in a preliminary exper-
iment (data not shown). No differences in cAMP levels
were observed between the untreated control preparation
and the preparation treated with ISO (10 nmol/L) or Salb
(60 nmol/L), but a significant increase in cAMP level was
observed in the preparation treated by Fors (1 m mol/L)
(Fig. 1).
Ca2+ sensitivity in skinned tracheal muscle
In the skinned tracheal muscle obtained by b -escin
treatment, contraction increased with increases in Ca2+
concentration in CSS (Fig. 2). Contraction was observed
at an intracellular Ca2+ concentration of 0.3 m mol/L and
a peak response was reached at 10 m mol/L, with an ED50
value of 1.26 m mol/L.
Effect of adrenergic b 2-agonists on skinned
muscle in the presence of GTP
With the intracellular Ca2+ concentration maintained at
1 m mol/L, the skinned muscle was treated with a b 2-
agonist for 90 min in the presence of GTP (100 m mol/L).
Treatment with ISO (10 nmol/L) or Salb (60 nmol/L) 
did not affect the Ca2+ sensitivity of the skinned muscle
(Fig. 3). However, when ISO (10 nmol/L) was added in
the presence of OA (1 m mol/L), a phosphatase inhibitor,
relaxation occurred slowly, and approximately 20% relax-
ation from the maximum contraction level was observed
after 30 min (Fig. 4). The same relaxation effect was also
observed with Salb (60 nmol/L) treatment.
The ISO- or Salb-induced relaxation was reproducible,
and the relaxation effect increased with increases in
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Fig. 2 Relationship between relative contraction and Ca2+
concentration in guinea-pig skinned tracheal muscle prepara-
tions. Skinned muscle preparations showed contraction
depending on the Ca2+ concentration in the solution. Points
show the mean values ± SEM (n = 5).
Fig. 1 Intracellular cAMP levels after adrenergic b 2-agonists
and forskolin administration. Intracellular cAMP levels were
measured by the cAMP enzyme immunoassay system. After
30 min of isobutyl-methylxanthine (0.1 mmol/L) treatment,
the preparations from intact tracheal muscle were treated for
16 min with isoproterenol (10 nmol/L), salbutamol (60 nmol/L)
or forskolin (1 m mol/L) at concentrations that caused maximum
relaxation. Only the Fors group showed significant increase
(P < 0.01) in cAMP levels compared with the control group.
Points show the mean values ± SEM (n = 3–12).
ISO concentration and treatment duration (Fig. 5). At
an ISO concentration of 1 nmol/L, significant relaxation
was observed after 30 min compared to the OA control,
whereas at an ISO concentration of 10 nmol/L, signifi-
cant relaxation was observed after 10 min. At a Salb
concentration of 60 nmol/L, significant relaxation was
observed after10 min.
The ISO- or Salb-induced relaxation in skinned muscle
in the presence of OA was significantly inhibited by 
pretreatment with propranolol (1 m mol/L) for 10 min
(Fig. 6).
Effect of Fors or cAMP on skinned muscle
The addition of Fors (1 m mol/L), an adenylate cyclase
activator, had no effect on the Ca2+ sensitivity of the
skinned muscle, regardless of the presence or absence of
OA (Fig. 7). No relaxation response was observed when
a high concentration (100 m mol/L) of cAMP was added.
DISCUSSION
We examined the mechanism of tracheal muscle relax-
ation due to adrenergic b 2-agonists using guinea-pig
skinned tracheal muscle obtained by b -escin treatment.
Various reports have provided evidence that the fast 
and strong tracheal relaxation induced by adrenergic 
b 2-agonists requires a decrease of intracellular Ca2+ con-
centration in smooth muscle.7,8 However, the mechanism
of the intracellular Ca2+ decrease is still being debated, 
in part because the action mechanisms of b 2-agonists
that cause a decreased Ca2+ level involve complicated
processes in the membrane such as ion channels,8–11 Ca2+
pumping13,14 and Ca2+ uptake into sarcoplasmic reticu-
lum.8,12 Therefore, these mechanisms cannot be studied in
a simple system. In the present study, we targeted only the
action of b 2-agonists on the contractile protein system by
using skinned muscle to exclude the various ion-channel
functions, electrical functions of the membrane and even
sarcoplasmic reticular functions, and by maintaining a
constant intracellular Ca2+ concentration.
Skinned-sample preparations have various experi-
mental advantages. b -Escin treatment results in small
openings in the cellular membrane. The intracellular ionic
composition, especially the intracellular Ca2+ concentra-
tion, can be set free through exchange with the cyto-
plasmic substitution solution. Since there is no influx or
efflux of ions through various ion channels, only the
contraction/relaxation responses caused by intracellular
proteins with large molecule sizes can be examined. In
addition, in the sarcoplasmic reticulum, the Ca2+ that acts
as the intracellular Ca2+ store was depleted by A23187
treatment, thereby excluding contraction/relaxation mecha-
nisms that involve the sarcoplasmic reticulum. These were
the experimental conditions in the present study.
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Fig. 3 Effect of adrenergic 
b 2 agonists on skinned prepara-
tions in the presence of
guanosine 5’-triphosphate (GTP).
The preparations were treated
with each b 2 agonist for 90 min
in the presence of 1 m mol/L
Ca2+ and 100 m mol/L GTP. Iso-
proterenol (a) or salbutamol (b)
did not affect contraction in the
skinned muscle preparations.
We measured the isotonic contraction in skinned prep-
arations. Contraction in skinned muscle preparations
is conventionally determined by placing the sample
horizontally in a measuring device and then recording
the isometric tension.18–20 In our experiment, isotonic
contraction was measured in the vertical direction. A
muscle preparation experimentally loaded with a con-
stant weight is similar to the physiological conditions in
the body before excision, and relaxation can be mea-
sured accurately.
Isotonic recordings showed that contraction responses
of the skinned tracheal muscle depended on the intra-
cellular Ca2+ concentration (Fig. 2). This contraction
response is caused by the formation of myosin-actin
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Fig. 4 Effect of adrenergic b 2 agonists in the presence of okadaic acid. Okadaic acid (OA; 1 m mol/L) administration in the pres-
ence of GTP (100 m mol/L) increased contraction. The OA-induced contraction was slowly relaxed by isoproterenol (a) or salbutamol
(b) treatment.
cross bridges as a result of the activation of myosin
light chain kinase (MLCK) through the formation of
the Ca2+-calmodulin complex, which depends on the
concentration of Ca2+. Contraction was observed in our
preparations at an intracellular Ca2+ concentration of
0.3 m mol/L.
With the intracellular Ca2+ concentration main-
tained at 1 m mol/L, the Ca2+-induced contraction was
enhanced by the addition of GTP (Fig. 3). A similar result
was obtained by the addition of GTPg S (data not shown).
These results suggest that GTP-binding protein activation
is associated with the increase in Ca2+ sensitivity. In other
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Fig. 5 Relaxation effect of adrenergic b 2 agonists in the presence of 1 m mol/L okadaic acid (OA). The relaxation effects of isopro-
terenol (a) or salbutamol (b) in skinned muscle preparations were concentration and time dependent. *P < 0.05, **P < 0.01
compared with the corresponding point in OA alone (s). (d), OA and 1 nmol/L isoproterenol; (m), OA and 10 nmol/L
isoproterenol; (r), OA and 60 nmol/L salbutamol. Points show the mean values ± SEM (n = 4).
Fig. 6 Effect of propranolol on the relaxation effect of adrenergic b 2 agonists. The relaxation effect induced by 10 nmol/L iso-
proterenol (a; –d–) or 60 nmol/L salbutamol (b; –r–) in skinned muscle preparations was significantly suppressed by pretreatment
with 1 m mol/L propranolol (--d--, --r--). *P < 0.05, **P < 0.01 compared with the corresponding point for the agonist alone.
Points show the mean values ± SEM (n = 3–4).
studies, the addition of GTP or GTPg S to skinned smooth
muscle increased the Ca2+ sensitivity of the muscles.21,22
In the presence of 1 m mol/L Ca2+ and 100 m mol/L
GTP, neither ISO (10 nmol/L) nor Salb (60 nmol/L)
affected the Ca2+ sensitivity (Fig. 3). However, both b 2-
agonists significantly inhibited the contraction induced
by OA (1 m mol/L) (Figs. 4,5). Considering the reports
that OA does not affect MLCK or phosphodiesterase of
guinea-pig taenia coli23 and that 1 m mol/L OA almost
completely and reversibly inhibits myosin light chain
phosphatase (MLCP),24 the contraction induced by OA in
our skinned tracheal muscle may be caused mainly by
the inhibition of dephosphorylation of the phosphorylated
myosin light chain. However, one cannot exclude the
possibility that the contraction may be the result of the
effect of OA, a non-specific phosphatase inhibitor, on
the actin side that interacts with phosphorylated myosin to
form cross bridges. The reason is that calponin and
caldesmon, which are thin filament regulatory proteins
associated with actin filaments, are present in the skinned
tracheal muscle. Phosphorylation of these proteins has
been reported to activate actomyosin ATPase and con-
tract tracheal muscle.25 Adrenergic b 2-agonist-induced
relaxation was observed in the presence of OA but not in
its absence (Figs 3,4). These results suggest that adrener-
gic b 2-agonists act on the OA targets: MLCP and other
protein phosphatases. Their activation causes relaxation.
The mechanisms by which the activities of these phos-
phatases are enhanced are unknown, and require further
studies.
In a preliminary experiment, we confirmed that the rel-
axation in isolated tracheal muscle induced by 10 nmol/L
of ISO was inhibited by 1 m mol/L propranolol. The
findings of complete inhibition of b 2-agonist-induced
relaxation in skinned muscles by propranolol (Fig. 6)
and the lack of a relaxation effect for Fors (Fig. 7) suggest
that activation of MLCP and other protein phosphatases
by b 2-agonists is not related to the intracellular cAMP
increase, but may be mediated by b 2-receptors in the
membrane.
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Fig. 7 Effect of forskolin and cAMP on skinned muscle preparations. The Ca2+ sensitivity of guinea-pig skinned tracheal muscle
preparations was not affected by the addition of forskolin (1 m mol/L) or cAMP (0.1 or 100 m mol/L).
In the present study, b 2-agonists were used at concen-
trations that did not increase the intracellular cAMP level
(Fig. 1). At these concentrations, b 2-agonists inhibited
OA-induced contraction (Figs 4,5). In addition, as shown
in Fig. 7, the Ca2+ sensitivity of the skinned muscle was
not affected by the addition of Fors that activates adeny-
late cyclase and increases the cAMP level (Fig. 1), and
was also not affected by cAMP at a concentration suf-
ficient to activate cAMP-dependent protein kinase (PKA).
Other studies have reported that skinned smooth muscle
preparations obtained by a -toxin treatment were relaxed
by Fors and cAMP,19,26 which is different from our results.
In our skinned preparation PKA efflux caused by b -escin
treatment may conceivably cause the difference in
findings. Savineau and Marthan18 used a b -escin con-
centration two-fold higher than that used in the present
study and reported inhibition of Ca2+-induced contrac-
tion by cAMP. Therefore, we may exclude the possibility of
PKA efflux from our skinned preparations. Contrary to the
result of Savineau and Marthan, cAMP and Fors did not
affect Ca2+ sensitivity in our skinned preparations. The
cause of this discrepancy is unknown, but may be due to
differences in response between human and guinea-pig
tracheal muscle, or it may be associated with partial PKA
efflux or other factors. Even if it is hypothesized that the
differences in the findings are due to PKA efflux from our
preparations, there is still a possibility that slow inhibition
of OA-induced contraction by adrenergic b 2-agonists is
due to phosphatase activation by unknown pathways dif-
ferent from that mediated by PKA. These results suggest
that the mechanism of tracheal smooth muscle relaxation
induced by b 2-agonists is not associated with adenylate
cyclase at a given concentration of Ca2+, but involves a
pathway that inhibits responses of the contractile protein
system.
Rapid tracheal smooth muscle relaxation induced by
low concentrations of adrenergic b 2-agonists, which is
considered useful experimentally or clinically, may be
a response caused by a rapid decrease of intracellular
Ca2+ due to signal transduction through the receptor-
G-protein. The present study suggests that low concentra-
tions of b 2-agonists not only lower intracellular Ca2+
concentration, but also activate protein phosphatase
via b 2-receptors and G-protein. The functional role
of protein phosphatase activation by b 2-agonists is
unknown, but it may have a modulating role in maintain-
ing and augmenting the b 2-agonist-induced relaxation
response that depends on lowered intracellular Ca2+
concentration.
Further studies are required to examine the mechanism
of relaxation by protein phosphatase activation induced
by adrenergic b 2-agonists.
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